Sando J J, Chertihin O I
Department of Pharmacology, University of Virginia, Charlottesville 22908, USA.
Biochem J. 1996 Jul 15;317 ( Pt 2)(Pt 2):583-8. doi: 10.1042/bj3170583.
Lysophosphatidic acid (LPA) has attracted recent attention as a major serum-derived regulator implicated in responses to vascular injury and inflammation, in tumour invasiveness and in neuronal signalling and remodelling. Although the possibility of a specific G-protein-coupled LPA receptor protein has been suggested, characterization of such a receptor is lacking. Since LPA can activate protein kinase C (PKC) pathways in many cells and PKC activators mimic many LPA effects, the possibility of more direct LPA effects on PKC was investigated. Phosphatidylcholine (PC)/phosphatidylserine (PS)/diacylglycerol (DAG) lipid vesicles of defined acyl chain composition were used to activate the enzyme. At total concentrations of saturated PC/PS + DAG vesicles (2-3 mM) that provided maximal PKC activation, 1-10 mol % [18:1]-LPA led to a further approx. 2-fold activation of PKC alpha. At lower lipid concentrations, a greater increase was observed with LPA concentrations up to 16-20 mol %. Higher concentrations of LPA were inhibitory. The LPA activation of PKC was dependent on the presence of DAG, PS and Ca2+. [18:1]-Lysophosphatidylcholine produced similar PKC activation in PC/PS/DAG vesicles. [14:0]-LPA was less effective, and longer-chain saturated lysolipids were ineffective. In unsaturated PC/PS vesicles, very little to no effect of LPA was discernable. These results suggest that physiologically or pathologically relevant concentrations of LPA can contribute to PKC activation depending on the composition of the lipid membrane. We hypothesize that LPA may affect the formation of lipid domains that are recognized by the enzyme.
溶血磷脂酸(LPA)作为一种主要的血清衍生调节剂,近来受到关注,它与血管损伤和炎症反应、肿瘤侵袭以及神经元信号传导和重塑有关。尽管已经有人提出存在一种特定的G蛋白偶联LPA受体蛋白,但对这种受体的特性描述仍很缺乏。由于LPA可在许多细胞中激活蛋白激酶C(PKC)途径,且PKC激活剂可模拟许多LPA的效应,因此研究了LPA对PKC更直接作用的可能性。使用具有确定酰基链组成的磷脂酰胆碱(PC)/磷脂酰丝氨酸(PS)/二酰基甘油(DAG)脂质囊泡来激活该酶。在提供最大PKC激活的饱和PC/PS + DAG囊泡总浓度(2 - 3 mM)下,1 - 10 mol%的[18:1]-LPA可使PKCα进一步激活约2倍。在较低脂质浓度下,当LPA浓度高达16 - 20 mol%时观察到更大的激活增加。更高浓度的LPA具有抑制作用。LPA对PKC的激活依赖于DAG、PS和Ca2+的存在。[18:1]-溶血磷脂酰胆碱在PC/PS/DAG囊泡中产生类似的PKC激活。[14:0]-LPA效果较差,长链饱和溶血脂质则无效。在不饱和PC/PS囊泡中,几乎看不到LPA有任何作用。这些结果表明,根据脂质膜的组成,生理或病理相关浓度的LPA可促进PKC激活。我们推测LPA可能影响该酶所识别的脂质结构域的形成。